This review decodes the aging of dental stem cells, highlighting mechanisms and innovative therapeutic strategies.
Dental stem cells (DSCs) hold immense potential in regenerative medicine due to their unique properties, including superior proliferative and differentiation capacities, robust immunomodulatory functions, and resilience to aging. However, the aging process profoundly impairs their functionality, diminishing their regenerative potential and limiting their clinical utility. This review provides a systematic examination of the mechanisms underlying DSC aging, focusing on disrupted signaling pathways, metabolic dysregulation, and epigenetic modifications, as well as the regulatory roles of non‐coding RNAs and critical proteins. It further investigates the key intrinsic and extrinsic factors driving this process, offering a comprehensive perspective on the interplay between cellular and systemic influences. Building on this foundation, the review explores innovative strategies to mitigate age‐related decline in DSCs, emphasizing approaches that target the extracellular matrix, mitochondrial dysfunction, and key molecular pathways. Finally, it addresses the challenges in translating these findings into clinical applications, such as inter‐individual variability and systemic influences, and advocates for multidisciplinary approaches to enhance therapeutic outcomes. Collectively, this review provides a critical framework for advancing the clinical translation of DSC‐based therapies, with broader implications for regenerative medicine in aging contexts.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: